Towards Healthcare
Cell and Gene Solutions Market Growth Led by Oncology and Rare Disorders

Cell and Gene Solutions Market 2025 to 2034 Global Landscape, Regulatory Momentum, and Strategic Investments

The growing demand for targeted therapeutics and new product launches drives the global market. North America dominated the global market due to the presence of key players and favorable infrastructure.

Content

  • Last Updated: 25 July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

Global cell and gene solutions market to grow rapidly by 2034, fueled by tech progress and consumer trends.

North America is leading the cell and gene solutions market due to the availability of state-of-the-art research and development facilities, the presence of key players, and favorable regulatory support.

The cell and gene solutions market includes five segments including by therapy type, by service technology, by application, by end-user, and by region.

Some key players include Thermo Fisher Scientific, Charles River Laboratories, and ABL Europe.

CGTs may induce a strong immune response to the protein in the case of replacing proteins from genetic diseases.

Food and Drug Administration, Government of Canada, clinicaltrials.gov, Association of the British Pharmaceutical Industry.
Any Questions